COMMENTARY: Lipid-lowering reduce cardiovascular events in type 2 diabetes

Gami, Apoor S.
November 2004
ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p65
Academic Journal
The article presents a commentary on the study, which concluded that lipid-lowering reduce cardiovascular events in type 2 diabetes. Recent guidelines recommended lipid-lowering therapy for all patients with diabetes. However, direct evidence to support this recommendation was lacking [2]. The study in question incorporated the latest data (some unpublished) in this meta-analysis and provides new and important insights into the role of lipid-lowering agents in these patients. The meta-analysis is well designed but lacks assessment of publication bias, quality assessments of trials, and adequate subgroup analyses to test explanations for between-trial differences.


Related Articles

  • Review: Lipid-lowering reduce cardiovascular events in type 2 diabetes.  // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p65 

    The article addresses the question whether in patients with type 2 diabetes mellitus, lipid-lowering agents reduce cardiovascular disease (CVD) events. To find out the answer, randomized controlled trials (RCTs) of lipid-lowering agents that evaluated major CVD events in patients with type 2...

  • Prevalence and trends of the diabetes epidemic in South Asia: a systematic review and meta-analysis. Jayawardena, Ranil; Ranasinghe, Priyanga; Byrne, Nuala M.; Soares, Mario J.; Katulanda, Prasad; Hills, Andrew P. // BMC Public Health;2012, Vol. 12 Issue 1, p380 

    Background: Diabetes mellitus has reached epidemic proportions worldwide. South Asians are known to have an increased predisposition for diabetes which has become an important health concern in the region. We discuss the prevalence of pre-diabetes and diabetes in South Asia and explore the...

  • CITATIONS AND CLINICIANS' NOTES: MANAGEMENT OF DIABETES.  // Current Medical Literature: Diabetes;2005, Vol. 22 Issue 1, p21 

    The article presents papers related to management of diabetes. The paper "Treatment Gap in the Use of Lipid-Lowering Drug Therapy in Diabetes: A Population-Based Study," by P. James, H.H. Tan and R. MacAlpine examines the use of lipid-lowering therapy compared with the presence of macrovascular...

  • The Relationship Between Diabetes Mellitus and Destructive Periodontal Disease: A Meta-Analysis. Chávarry, Nilo Guliberto Martins; Vettore, Mario Vianna; Sansone, Carmelo; Sheiham, Aubrey // Oral Health & Preventive Dentistry;2009, Vol. 7 Issue 2, p107 

    Purpose: The aim of this study was to systematically review the studies on the association between diabetes mellitus (DM) and destructive periodontal disease. Methods: The methods applied include a literature search strategy, inclusion and exclusion criteria for selecting the studies,...

  • Thiazolidinediones too heavy for bones of diabetic women.  // Reactions Weekly;1/31/2009, Issue 1237, p2 

    The article discusses research being done on thiazolidinediones. It references a study by Y. K. Loke et al published in the January 6, 2009 issue of "CMAJ: Canadian Medical Association Journal." Results of the meta-analysis revealed that long-term treatment with thiazolidinediones for type 2...

  • Aggressive lipid control fails to benefit type 2 diabetics. Campbell, Maude // Drug Topics;Jun2010, Vol. 154 Issue 6, p28 

    The article reports on the addition of fenofibrate to statin therapy can minimize cardiovascular events in patients with type 2 diabetes. It mentions that the combination lipid treatment can lower the risks of low density of lipoprotein (LDL) to patients with type 2 diabetes. According to...

  • DIABETES DELAYS, HOSPITAL ARRIVAL, AND EMERGENCY MANAGEMENT OF ACUTE CORONARY SYNDROMES (ACS). Foo, K.; Knight, C.; Deaner, A.; J. Cooper; Ranjadayalan, K.; Suliman, A.; Timmis, A. D. // Heart;May2004 Supplement 2, Vol. 90, pA32 

    This article focuses on a diabetes delays, hospital arrival, and emergency management of acute coronary syndromes (ACS). Diabetes is a major determinant of risk in ACS. It is also associated with altered pain perception that may distort symptoms and delay diagnosis. This study has shown that...

  • An evaluation of heart rate variability and its modifying factors in children with type 1 diabetes. Özgür, Senem; Ceylan, Özben; Şenocak, Filiz; Örün, Utku A.; Doğan, Vehbi; Yılmaz, Osman; Keskin, Mahmut; Aycan, Zehra; Okutucu, Sercan; Karademir, Selmin // Cardiology in the Young;Oct2014, Vol. 24 Issue 5, p872 

    Objective: To evaluate heart rate variability by Holter monitoring in type 1 diabetic children compared with a healthy control group and determine the factors modifying heart rate variability. Methods: This was designed as a prospective study comparing 28 patients, diagnosed with type 1 diabetes...

  • A Literature Review of the Use of Monochromatic Infrared Energy in Improving the Quality of Life in Patients with Peripheral Neuropathy Secondary to Diabetes Mellitus. Edmondson, Deborah; Flowers, Donielle; Upchurch, Angelita // Journal of the National Society of Allied Health;Spring/Summer2008, Vol. 5 Issue 6, p38 

    In America approximately 20.8 million people have Diabetes Mellitus. Peripheral neuropathy is a common symptom associated with Diabetes Mellitus. A meta-analysis was performed to determine the benefits of monochromatic infrared energy in the treatment of peripheral neuropathy resulting from...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics